The HIV type 1 coreceptor CCR5 and its role in viral transmission and disease progression

被引:0
|
作者
Paxton, WA [1 ]
Kang, S [1 ]
Koup, RA [1 ]
机构
[1] Aaron Diamond AIDS Res Ctr, New York, NY 10016 USA
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The purified CD4(+) lymphocytes of a group of highly exposed but HIV-1-uninfected individuals mere determined to be less susceptible to infection with multiple non-syncytium-inducing (NSI) primary isolates of HIV-1 than were CD4(+) lymphocytes from nonexposed control individuals. This relative resistance to HIV-1 infection did not extend to T cell line-adapted or syncytium-inducing (SI) primary viral isolates, mas restricted by the envelope glycoprotein, and was associated with an increased production of the C-C chemokines RANTES, MIP-1 alpha, and MIP-1 beta, The block to replication in CD4(+) lymphocytes from two exposed-uninfected subjects was at the point of entry, as was the block imposed by the recombinant C-C chemokines RANTES, MIP-1 alpha, and MIP-1 beta, Resistance to infection and the high production of beta chemokines were characteristic of every CD4(+) lymphocyte clone from the exposed-uninfected subjects. We have now identified the mechanism underlying this in vitro and in vivo resistance to infection: These individuals have inherited a homozygous 32-bp nucleotide deletion (Delta 32) within the gene encoding the coreceptor for primary NSI isolates of HIV-1 (CCR5), This deletion encodes a severely truncated and unstable protein that is not expressed on the cell surface. This allele is common in the Caucasian population, with a frequency of 0.0808, but is not found in people of African or Asian ancestry. To determine its role in HIV-1 transmission and disease progression, me analyzed the CCR5 genotype of 1252 homosexual men enrolled in the Chicago component of the Multicenter AIDS Cohort Study (MACS), No infected participant was found to be homozygous for the Delta 32 allele whereas 3.6% of at-risk but uninfected Caucasian participants were homozygous, showing the highly protective role of this genotype against sexual acquisition of HIV-1, No evidence was found to suggest that heterozygotes mere protected against HIV-1 infection, but a limited protective role against disease progression was noted. The Delta 32 allele of CCR5 is therefore an important host factor in HIV-1 transmission and pathogenesis.
引用
收藏
页码:S89 / S92
页数:4
相关论文
共 50 条
  • [31] Prevalence of CCR5 and CCR2 HIV-coreceptor gene polymorphisms in Belgium
    Struyf, F
    Thoelen, I
    Charlier, N
    Keyaerts, E
    Van der Donck, I
    Wuu, J
    Van Ranst, M
    HUMAN HEREDITY, 2000, 50 (05) : 304 - 307
  • [32] Enhanced expression, native purification, and characterization of CCR5, a principal HIV-1 coreceptor
    Mirzabekov, T
    Bannert, N
    Farzan, M
    Hofmann, W
    Kolchinsky, P
    Wu, LJ
    Wyatt, R
    Sodroski, J
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (40) : 28745 - 28750
  • [33] Theoretical Studies on the Interactions and Interferences of HIV-1 Glycoprotein gp120 and Its Coreceptor CCR5
    Da, Lin-tai
    Wu, Yun-Dong
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2011, 51 (02) : 359 - 369
  • [34] Transmembrane Protein Aptamers That Inhibit CCR5 Expression and HIV Coreceptor Function
    Scheideman, Elizabeth H.
    Marlatt, Sara A.
    Xie, Yanhua
    Hu, Yani
    Sutton, Richard E.
    DiMaio, Daniel
    JOURNAL OF VIROLOGY, 2012, 86 (19) : 10281 - 10292
  • [35] Prevalence and the role of CCR5Δ32 heterozygosity in disease progression in HIV positive patients in the Czech Republic
    Sacka, L.
    Hodek, J.
    Machala, L.
    Maly, M.
    Weber, J.
    EPIDEMIOLOGIE MIKROBIOLOGIE IMUNOLOGIE, 2019, 68 (03): : 138 - 143
  • [36] Causal pathways for CCR5 genotype and HIV progression
    Taylor, JMG
    Wang, Y
    Ahdieh, L
    Chmiel, JS
    Detels, R
    Giorgi, JV
    Kaslow, R
    Kingsley, L
    Margolick, J
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2000, 23 (02) : 160 - 171
  • [37] CCR5 genotype and resistance to vertical transmission of HIV-1
    Philpott, S
    Burger, H
    Charbonneau, T
    Grimson, R
    Vermund, SH
    Visosky, A
    Nachman, S
    Kovacs, A
    Tropper, P
    Frey, H
    Weiser, B
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1999, 21 (03): : 189 - 193
  • [38] Host genes and HIV: The role of the chemokine receptor gene CCR5 and its allele (Delta 32 CCR5)
    McNicholl, JM
    Smith, DK
    Qari, SH
    Hodge, T
    EMERGING INFECTIOUS DISEASES, 1997, 3 (03) : 261 - 271
  • [39] Modeling of CCR5 Recognition by HIV-1 gp120: How the Viral Protein Exploits the Conformational Plasticity of the Coreceptor
    Jacquemard, Celien
    Koensgen, Florian
    Colin, Philippe
    Lagane, Bernard
    Kellenberger, Esther
    VIRUSES-BASEL, 2021, 13 (07):
  • [40] Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression
    Smith, MW
    Dean, M
    Carrington, M
    Winkler, C
    Huttley, GA
    Lomb, DA
    Goedert, JJ
    OBrien, TR
    Jacobson, LP
    Kaslow, R
    Buchbinder, S
    Vittinghoff, E
    Vlahov, D
    Hoots, K
    Hilgartner, MW
    OBrien, SJ
    SCIENCE, 1997, 277 (5328) : 959 - 965